IN2014DN03010A - - Google Patents

Info

Publication number
IN2014DN03010A
IN2014DN03010A IN3010DEN2014A IN2014DN03010A IN 2014DN03010 A IN2014DN03010 A IN 2014DN03010A IN 3010DEN2014 A IN3010DEN2014 A IN 3010DEN2014A IN 2014DN03010 A IN2014DN03010 A IN 2014DN03010A
Authority
IN
India
Prior art keywords
compounds
methods
compositions
administering
producing
Prior art date
Application number
Inventor
Maxime Gualtieri
Guillot Philippe Villain
Alain Givaudan
Sylvie Pages
Original Assignee
Nosopharm
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nosopharm, Agronomique Inst Nat Rech filed Critical Nosopharm
Publication of IN2014DN03010A publication Critical patent/IN2014DN03010A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

The present invention relates to antibiotic compounds methods for producing said compounds pharmaceutical compositions comprising said compounds and methods of treatment comprising administering said compounds and/or compositions comprising said compounds.
IN3010DEN2014 2011-09-28 2012-09-28 IN2014DN03010A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161540085P 2011-09-28 2011-09-28
EP11183034 2011-09-28
PCT/EP2012/069166 WO2013045600A1 (en) 2011-09-28 2012-09-28 Novel peptide derivatives as antibiotics

Publications (1)

Publication Number Publication Date
IN2014DN03010A true IN2014DN03010A (en) 2015-05-08

Family

ID=47994311

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3010DEN2014 IN2014DN03010A (en) 2011-09-28 2012-09-28

Country Status (10)

Country Link
US (1) US9260481B2 (en)
EP (1) EP2760881B1 (en)
JP (1) JP6158188B2 (en)
CN (1) CN103827138B (en)
CA (1) CA2845735A1 (en)
ES (1) ES2657930T3 (en)
IL (1) IL231664A0 (en)
IN (1) IN2014DN03010A (en)
RU (1) RU2014114996A (en)
WO (1) WO2013045600A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102522224B1 (en) 2014-09-26 2023-04-14 노소팜 Novel peptide derivatives and uses thereof
US9800971B2 (en) 2015-03-17 2017-10-24 Knowles Electronics, Llc Acoustic apparatus with side port
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717299D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Peptides
FR2819514B1 (en) * 2001-01-12 2003-02-28 Rhobio ANTIMICROBIAL PSEUDOPEPTIDES
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
FR2946058A1 (en) * 2009-05-27 2010-12-03 Nosopharm PROCESS FOR INCREASING THE DIVERSITY OF SECONDARY METABOLITES OF INTEREST PRODUCED BY MICROORGANISMS

Also Published As

Publication number Publication date
US20150175659A1 (en) 2015-06-25
CA2845735A1 (en) 2013-04-04
EP2760881A1 (en) 2014-08-06
CN103827138A (en) 2014-05-28
WO2013045600A1 (en) 2013-04-04
JP2014534173A (en) 2014-12-18
ES2657930T3 (en) 2018-03-07
IL231664A0 (en) 2014-05-28
EP2760881B1 (en) 2017-11-01
CN103827138B (en) 2016-05-25
US9260481B2 (en) 2016-02-16
JP6158188B2 (en) 2017-07-05
RU2014114996A (en) 2015-11-10

Similar Documents

Publication Publication Date Title
IN2014MN00948A (en)
MD20150091A2 (en) Anti-viral compounds
IN2014MN00987A (en)
TN2015000278A1 (en) Autotaxin inhibitors
IN2014MN00988A (en)
IN2014MN02049A (en)
IN2014MN00986A (en)
IN2014MN02069A (en)
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
EP2872151A4 (en) Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
PH12015501609A1 (en) Phenicol antibacterials
IN2015DN01119A (en)
IN2015DN01151A (en)
MX353299B (en) Methods and compositions relating to p62 for the treatment and prophylaxis of cancer.
MX349224B (en) Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
SG10201900541QA (en) Derivatives of xanthone compounds
PH12014502065A1 (en) Vesicular formulations
IN2014DN03010A (en)
NZ707773A (en) Methods of treating liver diseases
MX347541B (en) Sialic acid analogs.
EP2785335B8 (en) Methods and pharmaceutical compositions for the treatment of darier disease
IN2015DN02109A (en)
MX2013003859A (en) Picropodophyllin polymorphs b or c for use in cancer therapy.
MX2014004742A (en) Novel phenicol antibacterials.